NeuroMetrix, Inc. (NASDAQ:NURO) hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $1.56 and last traded at $1.65, with a volume of 91400 shares traded. The stock had previously closed at $1.66.

Separately, HC Wainwright reiterated a “buy” rating and issued a $3.00 price objective (down previously from $10.00) on shares of NeuroMetrix in a research report on Friday, October 20th.

TRADEMARK VIOLATION NOTICE: This piece was first posted by Watch List News and is owned by of Watch List News. If you are reading this piece on another publication, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The legal version of this piece can be viewed at

NeuroMetrix Company Profile

NeuroMetrix, Inc is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests.

Receive News & Ratings for NeuroMetrix Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeuroMetrix Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.